市場調查報告書

骨髓穿刺濃縮液(BMAC)的全球市場 - 成長、趨勢、預測(2020年∼2025年)

Bone Marrow Aspirate Concentrates Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 921889
出版日期 內容資訊 英文 112 Pages
商品交期: 2-3個工作天內
價格
骨髓穿刺濃縮液(BMAC)的全球市場 - 成長、趨勢、預測(2020年∼2025年) Bone Marrow Aspirate Concentrates Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年01月01日內容資訊: 英文 112 Pages
簡介

全球骨髓穿刺濃縮液(BMAC)市場在2020年到2025年間,預測將以5.0%的年複合成長率成長。骨髓穿刺濃縮液(BMAC),由骨髓採集的液體製作,有益於骨的治癒。整形外科疾病和運動障礙的盛行率上升,美容外科產業的成長,整形外科手術的骨髓穿刺濃縮液(BMAC)產品用途的擴大等促進著這個市場成長。

本報告提供全球骨髓穿刺濃縮液(BMAC)市場調查,市場概要,各產品、用途、地區的市場規模的變化與預測,市場成長要素及阻礙因素分析,市場機會,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 簡介

  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 整形外科疾病和運動傷害的盛行率上升
    • 醫療費的增加
  • 市場阻礙因素
    • 高的故障率
  • 波特的五力分析
    • 買方議價能力
    • 供給企業談判力
    • 新加入業者的威脅
    • 替代品的威脅
    • 競爭企業間的敵對關係

第5章 市場區隔

  • 各產品
    • 骨髓穿刺濃縮液(BMAC)系統
    • 骨髓穿刺濃縮液(BMAC)配件
  • 各用途
    • 整形外科
    • 傷口護理
    • 末稍血管疾病
    • 血液癌症
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Arthrex, Inc
    • Aspire Medical Innovation
    • Cesca Therapeutics Inc
    • EmCyte Corporation
    • Globus Medical, Inc
    • MED & CARE Innovative Solutions
    • MK Alliance Inc. (TotipotentSC)
    • Ranfac Corporation
    • Terumo BCT
    • Zimmer Biomet Holdings, Inc

第7章 市場機會及未來趨勢

目錄
Product Code: 67471

Market Overview

The bone marrow aspirate concentrates market is expected to grow with a CAGR of 5.0%, during the forecast period. Bone marrow aspirate concentrate is made from the fluid which is taken from bone marrow. Bone marrow aspirate concentrate represents mononuclear cell concentration, red blood cell, immature myeloid precursors, granulocytes, and platelets which are derived through a minimally invasive procedure that avoids the risks of an open bone graft procedure and this cells can help in the healing of some bone and joint conditions. Increased prevalence of orthopedic diseases and sports injuries, with high growth of the cosmetic surgery industry and increasing applications of the bone marrow aspirate concentrate (BMAC) products in the cosmetic and orthopedic surgeries, are driving the growth of the bone marrow aspirate concentrate market.

Rising prevalence of osteoarthritis globally, due to the ageing population. According to the United Nations by the year 2050, people over 60 years age will account for more than 20% of the world's population, of which 130 million people will suffer from osteoarthritis worldwide, of whom 40 million will be severely disabled by the disease.

New technological advancements, favorable government regulations and increasing prevalence of orthopedic diseases are the factors that may further contribute to the bone marrow aspirate concentrate market growth. However, the high failure rate is likely to restrain the market growth in the forecast period.

Scope of the Report

Bone marrow aspirate concentrate is made from the fluid which is taken from bone marrow. Bone Marrow Aspirate Concentrates are segmented by Product (Bone Marrow Aspirate Concentrates Systems, Bone Marrow Aspirate Concentrates Accessories), Application and Geography.

Key Market Trends

Orthopedic Surgery Segment is Expected to Hold a Significant Market Share in the Bone Marrow Aspirate Concentrates

  • In the year 2017, approximately 22.3 million patients globally, undergone orthopedic surgery procedures. According to a collaborative survey, conducted by the United Nations and the World Health Organization (WHO), 80-90% in China are suffering from osteoarthritis, of which more than 55% are aged 60 years or above.
  • According to the World Health Organization (WHO), estimated that 9.6% of men and 18.0% of women aged over 60 years have symptomatic osteoarthritis.
  • Bone marrow-derived stem cell therapy is considered one of the promising and advanced treatment for osteoarthritis which reduces the injury healing time five to six weeks from four to six months in case of surgery.
  • Increasing prevalence of osteoarthritis and rising preference for bone marrow-derived stem cell therapy uses are the key factors for the growth of the bone marrow aspirate concentrates market.

North America is Expected to Dominate the Market and Expected to do Same in the Forecast Period

North America is expected to hold a major share globally in the bone marrow aspirate concentrates market due to rising prevalence of osteoarthritis diseases, rise in technological advancements and awareness about stem cell therapy in this region. Osteoarthritis (OA) is the most common joint disorder in the United States which occurs in 10% men and 13% in women aged 60 years or older. According to The Osteoarthritis Research Society International by the year 2030, an estimated 67 million adults aged 18 years and older will have doctor-diagnosed osteoarthritis. Furthermore, increasing the incidence of osteoarthritis diseases and a growing geriatric population in the country is fueling the growth of the overall regional market to a large extent.

Competitive Landscape

The Bone Marrow Aspirate Concentrates Market is moderately consolidated and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some players are adopting numerous strategies including acquisitions and collaborations to sustain competitive advantage. Some of the companies which are currently dominating the market are Ranfac Corp, Arthrex, Inc, Globus Medical, Inc, Terumo Corporation (Terumo BCT), Cesca Therapeutics Inc, Zimmer Biomet Holdings, Inc, MK Alliance Inc. (TotipotentSC), MED & CARE Innovative Solutions, Aspire Medical Innovation and EmCyte Corporation.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Orthopedic Diseases and Sports Injuries
    • 4.2.2 Rise in Healthcare Expenditure
  • 4.3 Market Restraints
    • 4.3.1 High Failure Rate
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Bone Marrow Aspirate Concentrates Systems
    • 5.1.2 Bone Marrow Aspirate Concentrates Accessories
  • 5.2 By Application
    • 5.2.1 Orthopedic Surgery
    • 5.2.2 Wound Healing
    • 5.2.3 Peripheral Vascular Disease
    • 5.2.4 Blood Cancer
    • 5.2.5 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Arthrex, Inc
    • 6.1.2 Aspire Medical Innovation
    • 6.1.3 Cesca Therapeutics Inc
    • 6.1.4 EmCyte Corporation
    • 6.1.5 Globus Medical, Inc
    • 6.1.6 MED & CARE Innovative Solutions
    • 6.1.7 MK Alliance Inc. (TotipotentSC)
    • 6.1.8 Ranfac Corporation
    • 6.1.9 Terumo BCT
    • 6.1.10 Zimmer Biomet Holdings, Inc

7 MARKET OPPORTUNITIES AND FUTURE TRENDS